🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 17% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
17% Evidence Coverage

Supplement Facts — Evidence Check

500 mg
📊 Market median: 500.0mg (283 products) 📚 173 studies (Tier A: 0, B: 62)
This product: 500mg
BioNMN
250 mg
ProGBB
50 mg
AstraGin
50 mg
📊 Market median: 20.0mg (9 products) 📚 5 studies — no high-quality reviews
This product: 20mg
Puremidine
1 mg

Other Ingredients

Rice Flour Cellulose Magnesium Stearate Silicon Dioxide

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (84% of products) Nutrient (23% of products) Qualified Health (1% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Directions: Take 1 capsule in the morning and 1 capsule in the evening with or without food.

⚠️ Warnings & Precautions

Warning: This product is only intended for use in healthy adults 18 years of age or older.

Pregnant or nursing women should not use this product. Consult your healthcare provider before using this product, especially if you are taking any prescription, over the counter medication, dietary supplement product, or if you have any pre-existing medical condition including but not limited to: high or low blood pressure, cardiac arrhythmia, stroke, heart, liver, kidney or thyroid disease, seizure disorder, psychiatric disease, diabetes, difficulty urinating due to prostate enlargement or if you are taking a MAOI (Monoamine Oxidase Inhibitor) or any other medication.

Consult your healthcare provider before using this product, especially if you are taking any prescription, over the counter medication, dietary supplement product, or if you have any pre-existing medical condition including but not limited to: high or low blood pressure, cardiac arrhythmia, stroke, heart, liver, kidney or thyroid disease, seizure disorder, psychiatric disease, diabetes, difficulty urinating due to prostate enlargement or if you are taking a MAOI (Monoamine Oxidase Inhibitor) or any other medication. Discontinue use and consult your health care professional if you experience adverse reaction to this product. Do not exceed recommended serving. Do not use if safety seal is broken or missing.

Keep out of reach of children.

Warning: Consuming this product can expose you to chemicals including lead, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

🧪 Formulation Notes

Comprehensive mitochondrial health support

Manufactured in a U.S. cGMP facility.

Product Details

UPC / SKU 6 58580 07092 2
DSLD Entry Date 2023-10-24
Product Type Other Combinations
Form Capsule
DSLD ID 298118
Data Updated 2026-04-11

Research Evidence

184 Research Sources
55 Avg Quality Score
91 Systematic Review
75 Meta Analysis
7 Rct
7 Clinical Trial
2 Cochrane Review
1 Openfda Safety
B Treatment of gouty arthritis with traditional Chinese medicine decoction: Meta-analysis, network pharmacology analysis, and molecular docking
Meta Analysis Medicine 2024
B Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2017
B Dietary polyphenols and the risk of metabolic syndrome: a systematic review and meta-analysis
Meta Analysis BMC endocrine disorders 2024
B Quercetin and endurance exercise capacity: a systematic review and meta-analysis
Meta Analysis Medicine and science in sports and exercise 2011
B Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis
Meta Analysis PloS one 2013
B Clinical efficacy evaluation and potential mechanism prediction on Guizhi-Shaoyao-Zhimu decoction in the treatment of gouty arthritis based on meta-analysis, network pharmacology analysis, and molecular docking
Meta Analysis Medicine 2023
B A Systematic Review: Quercetin-Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability
Systematic Review International journal of molecular sciences 2024
B Dietary flavonoid for preventing colorectal neoplasms.
Cochrane Review The Cochrane database of systematic reviews
B Flavonoids for treating venous leg ulcers.
Cochrane Review The Cochrane database of systematic reviews
B The effects of quercetin supplementation on lipid profiles and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2020
View all evidence for Quercetin →

Compare Similar Products

View all Quercetin products →